High Purity 4,7-Dichloroquinoline 99.5%+ for API Synthesis from Japan
Ultra-high purity 4,7-dichloroquinoline (>99.5%) specifically manufactured for active pharmaceutical ingredient synthesis, classified under HTS 2933.49.08.00 as a chemically defined quinoline derivative. Meets stringent pharma intermediate specifications.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include CoA with HPLC/GC purity data and heavy metal specifications for FDA/USDA review
• Pre-register with FDA Drug Master File if destined for US pharma production
• GMP manufacturing evidence prevents reclassification as technical grade